SAGA Diagnostics

SAGA Diagnostics

Private
Morrisville, North CarolinaHealthcare & Life Scienceshttps://sagadiagnostics.com

Last Round

Series A

Extension

Jun 29, 2021

Total Funding Raised

$17.2M

Company Overview

SAGA Diagnostics is a biotechnology company that provides ultrasensitive liquid biopsy tests for cancer diagnosis, monitoring, and recurrence detection.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

liquid biopsyctDNAmolecular residual diseaseMRD testingtumor-informed MRDcancer recurrence monitoringprecision oncologycirculating tumor DNAstructural variantstreatment response monitoringoncology diagnosticsassay developmentclinical trial supportdPCR assaysreagent kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SAGA Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SAGA Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 29, 2021
Series AJun 11, 2019
GrantNov 15, 2018
SeedApr 4, 2016

Key People

Founding team and executive leadership

Brian Dow

Chief Financial Officer

Executive Team

SAGA Diagnostics Investors

Notable investors and investment history

InvestorRounds
VinnovaGrant
SwelifeGrant
Segulah Medical AccelerationSeries A Extension
Hadean VenturesSeries A Extension, Series A
Fårö CapitalSeries A
Gunnar Nilsson Cancer FoundationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    New data for Pathlight MRD platform to be presented at AACR 2026.

  • Apr 17, 2026

    Presenting data at the 2026 AACR Annual Meeting in San Diego.

SAGA Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SAGA Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SAGA Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMorrisville, North Carolina
Employee Range96
Year Founded2016
Last FundingJun 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.